Open AccessIs intranasal dexmedetomidine superior to oral chloral hydrate for procedural sedation in children: A systematic review
Author(s) -
MohamedB Delvi
Publication year - 2022
Publication title -
saudi journal of anaesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.416
H-Index - 24
eISSN - 1658-354X
pISSN - 0975-3125
DOI - 10.4103/sja.sja_489_21
Subject(s) - medicine , chloral hydrate , dexmedetomidine , sedation , anesthesia , randomized controlled trial , adverse effect , tolerability , nausea , onset of action , vomiting , surgery
This systematic review was undertaken to compare the benefits of intranasal dexmedetomidine (IND) versus oral chloral hydrate (OCH) in the pediatric age group undergoing procedural sedation analgesia (PSA). Randomized clinical trials (RCT) of the various studies done over the years were taken up and analyzed. Since IND has the additional advantages of a faster onset of action, greater success with a single bolus dose, and enhanced recovery, this systematic review was conducted to prove the superiority of IND over OCH in pediatric PSA.